MYC rearrangements occur in 5–15% of diffuse large B-cell lymphomas (DLBCL), 20–35% of high-grade B-cell lymphoma, NOS (HGBL-NOS), and 90% of Burkitt lymphoma (BL). The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.